Correction to: Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population

被引：0
|
作者：
Alpesh Amin
Allison Keshishian
Oluwaseyi Dina
Amol Dhamane
Anagha Nadkarni
Eric Carda
Cristina Russ
Lisa Rosenblatt
Jack Mardekian
Huseyin Yuce
Christine L. Baker
机构：
[1] University of California,Department of Medicine
[2] STATinMED,New York City College of Technology
[3] Pfizer Inc.,undefined
[4] Bristol-Myers Squibb Company,undefined
[5] City University of New York,undefined
来源：
Journal of Thrombosis and Thrombolysis | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the article by Amin et al., “Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population” which was published online on March 28, 2019 (J Thromb and Thrombolysis 48:240–249), 2019, corrections are needed.
引用
收藏
页码：552 / 558
页数：6
相关论文
共 50 条
  • [1] Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
    Amin, Alpesh
    Keshishian, Allison
    Dina, Oluwaseyi
    Dhamane, Amol
    Nadkarni, Anagha
    Carda, Eric
    Russ, Cristina
    Rosenblatt, Lisa
    Mardekian, Jack
    Yuce, Huseyin
    Baker, Christine L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 240 - 249
  • [2] Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
    Alpesh Amin
    Allison Keshishian
    Oluwaseyi Dina
    Amol Dhamane
    Anagha Nadkarni
    Eric Carda
    Cristina Russ
    Lisa Rosenblatt
    Jack Mardekian
    Huseyin Yuce
    Christine L. Baker
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 240 - 249
  • [3] Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population (vol 48, pg 240, 2019)
    Amin, Alpesh
    Keshishian, Allison
    Dina, Oluwaseyi
    Dhamane, Amol
    Nadkarni, Anagha
    Carda, Eric
    Russ, Cristina
    Rosenblatt, Lisa
    Mardekian, Jack
    Yuce, Huseyin
    Baker, Christine L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (02) : 552 - 558
  • [4] Comparative Outcomes of Direct Oral Anticoagulants versus Warfarin in Morbidly Obese Patients With Non-valvular Atrial Fibrillation
    Barakat, Amr F.
    Jain, Sandeep
    Masri, Ahmad
    Senussi, Mourad
    Wang, Yisi
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh R.
    CIRCULATION, 2019, 140
  • [5] Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation Who Switched from Warfarin to Direct Oral Anticoagulants in Medicare Population
    Atreja, Nipun
    Dubey, Anandkumar
    Kang, Amiee
    Jiang, Jenny
    Hagan, Melissa
    Michael-Asalu, Abimbola
    Cheng, Dong
    Deitelzweig, Steven
    ADVANCES IN THERAPY, 2025, 42 (03) : 1462 - 1483
  • [6] EVALUATION OF EFFECTIVENESS AND SAFETY OUTCOMES AMONG MEDICARE PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION WHO SWITCHED FROM WARFARIN TO DIRECT ORAL ANTICOAGULANTS
    Atreja, Nipun
    Noxon, Virginia
    Kang, Amiee
    Hines, Dionne
    Jiang, Jenny
    Hagan, Melissa
    Cheng, Dong
    Abramovitz, Lisa
    Maynard, Jason
    Deitelzweig, Steven Bruce
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1242 - 1242
  • [7] Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
    Amin, A.
    Keshishian, A.
    Zhang, Q.
    Dina, O.
    Dhamane, A.
    Nadkarni, A.
    Carda, E.
    Liu, X.
    Rosenblatt, L.
    Baser, O.
    Baker, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1005 - 1005
  • [8] Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study
    Lip, G. Y. H.
    Keshishian, A.
    Li, X.
    Hamilton, M.
    Masseria, C.
    Dhamane, A.
    Luo, X.
    Mardekian, J.
    Friend, K.
    Nadkarni, A.
    Pan, X.
    Baser, O.
    Deitelzweig, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 506 - 506
  • [9] Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
    Dhamane, Amol D.
    Ferri, Mauricio
    Keshishian, Allison
    Russ, Cristina
    Atreja, Nipun
    Gutierrez, Cynthia
    Emir, Birol
    Yuce, Huseyin
    Di Fusco, Manuela
    ADVANCES IN THERAPY, 2023, 40 (03) : 887 - 902
  • [10] Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
    Amol D. Dhamane
    Mauricio Ferri
    Allison Keshishian
    Cristina Russ
    Nipun Atreja
    Cynthia Gutierrez
    Birol Emir
    Huseyin Yuce
    Manuela Di Fusco
    Advances in Therapy, 2023, 40 : 887 - 902
12345